Bethesda, MD (PRWEB) October 30, 2007 -- The International Lyme and Associated Diseases Society (ILADS) announced today that it has elected Dr. Daniel Cameron to serve as the new President of the Board for the next two years.The appointment was announced during the annual ILADS conference that drew more than 300 attendees that included medical practitioners and researchers who specialize in Lyme Disease and representatives from patient advocacy groups.

 

Dr. Cameron is the chief author of the ILADS evidence-based medicine practice guidelines.The ILADS treatment guidelines are based on evidence that Lyme is a complex disease, with symptoms that can vary significantly in patients.The ILADS guidelines are in direct conflict with the current accepted guidelines which support a view of Lyme as a simple disease that requires short doses of antibiotics as treatment.

"Lyme disease has become a major epidemic in this country," said Dr. Cameron."It is a complex and debilitating disease for many people.As president of the board, I hope to help bring researchers and practicing physicians together to identify better ways to diagnose and treat Lyme."

Cameron is an attending physician at the Northern Westchester Hospital and has served as an ILADS board member for the last six years.Cameron has made many contributions to clinical research on Lyme disease.He has pioneered the field of clinical epidemiology in Lyme disease as an author of practice guidelines, analytic reviews, and clinical trials.He continues to devote much of his research time to improving the outcomes of Lyme disease patients.

Cameron succeeds Dr. Raphael Stricker, who has served as ILADS president for the last two years.

Add to: del.icio.us | Digg